CMG Pharmaceutical Co., Ltd.
Research CMG Pharmaceutical Co., Ltd. (058820.KQ) on Bullrun: market cap KRW 83.25B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker058820.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 83.25B
- Financial periodQ2 2026
- RevenueKRW 28.26B
- Net incomeKRW 2.13B
- Free cash flow-KRW 10.80B
- Gross margin52.9%
Valuation Snapshot
latest market cap is KRW 83.25B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | KRW 83.25B | n/a | n/a | n/a |
Dividend history
About CMG Pharmaceutical Co., Ltd.
CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is CMG Pharmaceutical Co., Ltd.'s market cap?
CMG Pharmaceutical Co., Ltd.'s market capitalization is KRW 83.25B.
What does CMG Pharmaceutical Co., Ltd. do?
CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013.